Liquidia Corp — Investor Relations & Filings
Liquidia Corp is a biopharmaceutical company dedicated to the development and commercialization of therapies for rare cardiopulmonary diseases. The company focuses on addressing unmet needs in conditions such as pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). A core component of its strategy is the proprietary PRINT® technology, a particle engineering platform used to create precisely uniform drug particles. This technology is designed to enhance the efficacy, tolerability, and convenience of medicines, particularly through innovative delivery methods like inhaled therapies. Liquidia's pipeline is focused on advancing treatments to improve outcomes for patients with these serious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Liquidia Corp (0001819576) (Filer) | 2026-05-11 | English | |
| 8-K - Liquidia Corp (0001819576) (Filer) | 2026-05-11 | English | |
| ARS - Liquidia Corp (0001819576) (Filer) | 2026-04-24 | English | |
| 144 - Liquidia Corp (0001819576) (Subject) | 2026-03-27 | English | |
| 144 - Liquidia Corp (0001819576) (Subject) | 2026-03-26 | English | |
| 4 - Liquidia Corp (0001819576) (Issuer) | 2026-03-25 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
|
Bioceltix S.A.
Develops stem cell-based medicinal products for veterinary …
|
BCX | PL | Manufacturing |
|
BioChem Pharma Inc.
Produces and commercializes high-quality pharmaceuticals, f…
|
— | CA | Manufacturing |
Liquidia Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31694/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31694 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31694 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31694 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31694}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Liquidia Corp (id: 31694)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.